Raising unitranche for Bioscript to support two material bolt-on acquisitions
Bioscript is a leading global provider of medical communications and regulatory writing services for pharmaceutical companies. The business delivers its services through high quality staff to top-50 pharmaceutical companies.
Bioscript has made two material strategic acquisitions that more than double its EBITDA: Fortis Pharma Consulting, a speciality medical affairs services provider; and Vaild Insight, a specialist market access consultancy.
BDO Debt Advisory successfully advised on this complex transaction to fund the acquisitions and the subsequent earn-out. The flexible facility can re-leverage and automatically reset financial covenants to support its ongoing buy and build strategy.
"BDO Debt Advisory’s absolute commitment, problem solving approach and consultative communication style were instrumental factors in the success of this complex transaction. They succinctly packaged the credit story to maximise lender traction and skilfully negotiated an innovative debt solution that supports our ambitious buy and build strategy. We look forward to working with them again in the future."
Trevor Stokes, Investment Director, Soverign Capital Partners LLP